4570 Immuno-Biological Laboratories Co.,Ltd.免疫生物研究所TSE Growth / Pharmaceuticals
0 posts
Immuno-Biological Laboratories Co.,Ltd. (4570) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Immuno-Biological Laboratories Co.,Ltd. (4570) Stock Price HistoryNear a 52-week low
Immuno-Biological Laboratories Co.,Ltd. closed at ¥850 on Nov 20, 2026, −15.4% over 1 month, −40.8% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥84,577 today (−15.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −15.4%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥850 | −60 | −6.59% |
| Nov 19 (Thu) | ¥910 | +22 | +2.48% |
| Nov 18 (Wed) | ¥888 | −9 | −1.00% |
| Nov 17 (Tue) | ¥897 | −11 | −1.21% |
| Nov 16 (Mon) | ¥908 | −9 | −0.98% |
| Nov 13 (Fri) | ¥917 | −14 | −1.50% |
| Nov 12 (Thu) | ¥931 | −43 | −4.41% |
| Nov 11 (Wed) | ¥974 | −10 | −1.02% |
| Nov 10 (Tue) | ¥984 | +57 | +6.15% |
| Nov 9 (Mon) | ¥927 | +12 | +1.31% |
If you had invested ¥100,000 3 months ago, it would be worth ¥77,413 today (−22.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −22.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥850 | −60 | −6.59% |
| Nov 19 (Thu) | ¥910 | +22 | +2.48% |
| Nov 18 (Wed) | ¥888 | −9 | −1.00% |
| Nov 17 (Tue) | ¥897 | −11 | −1.21% |
| Nov 16 (Mon) | ¥908 | −9 | −0.98% |
| Nov 13 (Fri) | ¥917 | −14 | −1.50% |
| Nov 12 (Thu) | ¥931 | −43 | −4.41% |
| Nov 11 (Wed) | ¥974 | −10 | −1.02% |
| Nov 10 (Tue) | ¥984 | +57 | +6.15% |
| Nov 9 (Mon) | ¥927 | +12 | +1.31% |
If you had invested ¥100,000 6 months ago, it would be worth ¥71,189 today (−28.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −28.8%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥850 | −17.2% |
| Oct 2026 | ¥1,027 | −14.3% |
| Sep 2026 | ¥1,199 | +12.1% |
| Aug 2026 | ¥1,070 | +14.4% |
| Jul 2026 | ¥935 | −2.9% |
| Jun 2026 | ¥963 | −10.8% |
| May 2026 | ¥1,079 | −19.1% |
If you had invested ¥100,000 1 year ago, it would be worth ¥59,192 today (−40.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −40.8%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥850 | −17.2% |
| Oct 2026 | ¥1,027 | −14.3% |
| Sep 2026 | ¥1,199 | +12.1% |
| Aug 2026 | ¥1,070 | +14.4% |
| Jul 2026 | ¥935 | −2.9% |
| Jun 2026 | ¥963 | −10.8% |
| May 2026 | ¥1,079 | −19.1% |
| Apr 2026 | ¥1,334 | −0.6% |
| Mar 2026 | ¥1,342 | −20.4% |
| Feb 2026 | ¥1,686 | +9.8% |
| Jan 2026 | ¥1,536 | −18.9% |
| Dec 2025 | ¥1,895 | −39.3% |
| Nov 2025 | ¥3,120 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥153,153 today (+53.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +53.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥850 | −55.1% |
| 2025 | ¥1,895 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥202,381 today (+102.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +102.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥850 | −55.1% |
| 2025 | ¥1,895 | ― |
If you had invested ¥100,000 in Sep 2007, it would be worth ¥186,404 today (+86.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +236.2%, while this stock moved +86.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥850 | −55.1% |
| 2025 | ¥1,895 | +311.1% |
| 2024 | ¥461 | −6.5% |
| 2023 | ¥493 | +64.3% |
| 2022 | ¥300 | −11.8% |
| 2021 | ¥340 | −34.2% |
| 2020 | ¥517 | −24.4% |
| 2019 | ¥684 | +14.8% |
| 2018 | ¥596 | −21.2% |
| 2017 | ¥756 | −6.4% |
| 2016 | ¥808 | −21.0% |
| 2015 | ¥1,023 | −2.0% |
| 2014 | ¥1,044 | −22.1% |
| 2013 | ¥1,341 | +172.3% |
| 2012 | ¥493 | +10.8% |
| 2011 | ¥445 | +326.2% |
| 2010 | ¥104 | −14.5% |
| 2009 | ¥122 | +47.0% |
| 2008 | ¥83.0 | −81.8% |
| 2007 | ¥456 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Sep 2007). Please check the latest prices before trading.
Immuno-Biological Laboratories Co.,Ltd. (4570) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Immuno-Biological Laboratories Co.,Ltd. (4570)
Business overview
Together with two consolidated subsidiaries, the company runs antibody and cosmetics businesses. The antibody business consists of diagnostic reagent services, testing services and transgenic silkworm services. Diagnostic reagent services make and sell antibody-based research reagents (such as ELISA kits and antibodies), in vitro diagnostics and their raw materials, provide reagent-related contract services and out-license drug seeds. Testing services, centered on LipoSEARCH, provide detailed lipoprotein analysis for clinical and basic research, veterinary medicine and private practice, and also take on contract research measurements at its registered clinical laboratory, 「IBL解析センター」, inside its 「藤岡研究所」. Transgenic silkworm services provide contract services using technology that efficiently mass-produces target proteins and antibodies inside silkworm cocoons, and make and sell human-type collagen. The cosmetics business develops and sells cosmetics containing 「ネオシルク」-human-type collagen I.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 0.88% | No. 36 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 22.8x | Above the sector median of 16.5x (No. 28 from the lowest) |
| PBR | 4.01x | Above the sector median of 1.86x (No. 60 from the lowest) |
| ROE | 17.58% | No. 3 in the sector (highest first); median 4.17% |
| Market cap | ¥7.9 bn | No. 49 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥3,820 | 2025/12/1 |
|---|---|---|
| 52-week low | ¥850 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥850) |
| Year to date | -55.1% | No. 73 of 77 in the sector (best first) |
| 1 year | -40.8% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/11 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
Filings from the past 12 months (1).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Immuno-Biological Laboratories Co.,Ltd. board
More Japanese stocks in English
- Nano Holdings,Inc.4571
- Carna Biosciences,Inc.4572
- TAIKO PHARMACEUTICAL CO.,LTD.4574
- CanBas Co.,Ltd.4575
- D.Western Therapeutics Institute, Inc.4576
- Daito Pharmaceutical Co.,Ltd.4577
- RaQualia Pharma Inc.4579
- Le Lien Co.,Ltd.457A
- SymBio Pharmaceuticals Limited4582
- Chiome Bioscience Inc.4583
- Kidswell Bio Corporation4584
- Medrx Co.,Ltd.4586